Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
1.760
+0.070 (4.14%)
At close: Dec 5, 2025, 4:00 PM EST
1.714
-0.046 (-2.63%)
After-hours: Dec 5, 2025, 4:59 PM EST
Edesa Biotech Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
16
Market Cap
12.39M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
EDSA News
- 5 weeks ago - Edesa Biotech Announces Upcoming Conference Schedule - GlobeNewsWire
- 5 weeks ago - Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study - GlobeNewsWire
- 4 months ago - Edesa Biotech Posts Narrower Loss in Q3 - The Motley Fool
- 4 months ago - Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results - GlobeNewsWire
- 7 months ago - Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results - GlobeNewsWire
- 7 months ago - Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference - GlobeNewsWire
- 8 months ago - Edesa Biotech Announces Chief Financial Officer Transition - GlobeNewsWire
- 10 months ago - Edesa Biotech Reports Fiscal 1st Quarter 2025 Results - GlobeNewsWire